# Repay Holdings Corp: financial statements, quarterly

RPAY · Nasdaq · CIK 1720592 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rpay.md) · [Financials](/companies/rpay/financials.md) · [Filings](/companies/rpay/filings.md) · [Insiders](/companies/rpay/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rpay/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [74.3](/filings/0000950170-24-125459.md) | [76.0 d](/filings/0001193125-26-098518.md) | [80.7](/filings/0000950170-25-069191.md) | [74.9](/filings/0001720592-25-000011.md) | [79.1](/filings/0001193125-25-274252.md) | [78.3 d](/filings/0001193125-26-098518.md) | [77.3](/filings/0001193125-26-204011.md) | [75.6](/filings/0001193125-26-342440.md) | [77.7](/filings/0001193125-25-274252.md) | [78.6 d](/filings/0001193125-26-098518.md) | [80.8](/filings/0001193125-26-204011.md) | [101](/filings/0001193125-26-342440.md) |
| Cost of revenue | $m | [17.6](/filings/0000950170-24-125459.md) | [17.3 d](/filings/0001193125-26-098518.md) | [19.2](/filings/0000950170-25-069191.md) | [16.3](/filings/0001720592-25-000011.md) | [17.6](/filings/0001193125-25-274252.md) | [18.6 d](/filings/0001193125-26-098518.md) | [18.7](/filings/0001193125-26-204011.md) | [18.4](/filings/0001193125-26-342440.md) | [19.9](/filings/0001193125-25-274252.md) | [20.2 d](/filings/0001193125-26-098518.md) | [19.3](/filings/0001193125-26-204011.md) | [30.1](/filings/0001193125-26-342440.md) |
| Gross profit | $m | [56.7](/filings/0000950170-24-125459.md) | [58.7 d](/filings/0001193125-26-098518.md) | [61.5](/filings/0000950170-25-069191.md) | [58.6](/filings/0001720592-25-000011.md) | [61.6](/filings/0001193125-25-274252.md) | [59.7 d](/filings/0001193125-26-098518.md) | [58.7](/filings/0001193125-26-204011.md) | [57.2](/filings/0001193125-26-342440.md) | [57.8](/filings/0001193125-25-274252.md) | [58.3 d](/filings/0001193125-26-098518.md) | [61.5](/filings/0001193125-26-204011.md) | [70.6](/filings/0001193125-26-342440.md) |
| Selling, general and administrative | $m | [35.3](/filings/0000950170-24-125459.md) | [36.7 d](/filings/0001193125-26-098518.md) | [37.0](/filings/0000950170-25-069191.md) | [35.2](/filings/0001720592-25-000011.md) | [36.7](/filings/0001193125-25-274252.md) | [36.5 d](/filings/0001193125-26-098518.md) | [37.0](/filings/0001193125-26-204011.md) | [32.9](/filings/0001193125-26-342440.md) | [35.2](/filings/0001193125-25-274252.md) | [37.0 d](/filings/0001193125-26-098518.md) | [36.0](/filings/0001193125-26-204011.md) | [46.2](/filings/0001193125-26-342440.md) |
| Operating income | $m | [(5.1)](/filings/0000950170-24-125459.md) | [(78.5) d](/filings/0001193125-26-098518.md) | [(2.5)](/filings/0000950170-25-069191.md) | [(3.4)](/filings/0001720592-25-000011.md) | [(0.7)](/filings/0001193125-25-274252.md) | [(1.2) d](/filings/0001193125-26-098518.md) | [(3.6)](/filings/0001193125-26-204011.md) | [(105)](/filings/0001193125-26-342440.md) | [(3.0)](/filings/0001193125-25-274252.md) | [(143) d](/filings/0001193125-26-098518.md) | [(0.0)](/filings/0001193125-26-204011.md) | [(3.3)](/filings/0001193125-26-342440.md) |
| Interest expense | $m | not reported | not reported | [0.9](/filings/0000950170-25-069191.md) | [0.9](/filings/0001720592-25-000011.md) | [2.9](/filings/0001193125-25-274252.md) | [3.1 d](/filings/0001193125-26-098518.md) | [3.1](/filings/0001193125-26-204011.md) | [3.1](/filings/0001193125-26-342440.md) | [3.1](/filings/0001193125-25-274252.md) | [4.7 d](/filings/0001193125-26-098518.md) | [3.8](/filings/0001193125-26-204011.md) | [8.0](/filings/0001193125-26-342440.md) |
| Income tax | $m | [(2.0)](/filings/0000950170-24-125459.md) | [(3.4) d](/filings/0001193125-26-098518.md) | [0.3](/filings/0000950170-25-069191.md) | [(2.0)](/filings/0001720592-25-000011.md) | [1.5](/filings/0001193125-25-274252.md) | [(0.4) d](/filings/0001193125-26-098518.md) | [(0.5)](/filings/0001193125-26-204011.md) | [(1.3)](/filings/0001193125-26-342440.md) | [(1.8)](/filings/0001193125-25-274252.md) | [(2.3) d](/filings/0001193125-26-098518.md) | [2.0](/filings/0001193125-26-204011.md) | [(2.7)](/filings/0001193125-26-342440.md) |
| Net income | $m | [(6.2)](/filings/0000950170-24-125459.md) | [(73.3) d](/filings/0001193125-26-098518.md) | [(5.2)](/filings/0000950170-25-069191.md) | [(4.1)](/filings/0001720592-25-000011.md) | [3.2](/filings/0001193125-25-274252.md) | [(4.1) d](/filings/0001193125-26-098518.md) | [(7.9)](/filings/0001193125-26-204011.md) | [(102)](/filings/0001193125-26-342440.md) | [(6.4)](/filings/0001193125-25-274252.md) | [(140) d](/filings/0001193125-26-098518.md) | [(9.9)](/filings/0001193125-26-204011.md) | [(11.0)](/filings/0001193125-26-342440.md) |
| Diluted EPS | $ per share | [(0.07)](/filings/0000950170-24-125459.md) | not reported | [(0.06)](/filings/0000950170-25-069191.md) | [(0.04)](/filings/0001720592-25-000011.md) | [0.03](/filings/0001193125-25-274252.md) | not reported | [(0.09)](/filings/0001193125-26-204011.md) | [(1.15)](/filings/0001193125-26-342440.md) | [(0.08)](/filings/0001193125-25-274252.md) | not reported | [(0.12)](/filings/0001193125-26-204011.md) | [(0.13)](/filings/0001193125-26-342440.md) |
| Basic EPS | $ per share | [(0.07)](/filings/0000950170-24-125459.md) | not reported | [(0.06)](/filings/0000950170-25-069191.md) | [(0.04)](/filings/0001720592-25-000011.md) | [0.04](/filings/0001193125-25-274252.md) | not reported | [(0.09)](/filings/0001193125-26-204011.md) | [(1.15)](/filings/0001193125-26-342440.md) | [(0.08)](/filings/0001193125-25-274252.md) | not reported | [(0.12)](/filings/0001193125-26-204011.md) | [(0.13)](/filings/0001193125-26-342440.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [118](/filings/0000950170-23-062104.md) | [118](/filings/0001193125-26-098518.md) | [128](/filings/0000950170-24-056968.md) | [147](/filings/0001720592-25-000011.md) | [169](/filings/0001193125-25-274252.md) | [190](/filings/0001193125-26-098518.md) | [165](/filings/0001193125-26-204011.md) | [163](/filings/0001193125-26-342440.md) | [95.7](/filings/0001193125-25-274252.md) | [116](/filings/0001193125-26-342440.md) | [43.8](/filings/0001193125-26-204011.md) | [83.7](/filings/0001193125-26-342440.md) |
| Current assets | $m | [169](/filings/0000950170-23-062104.md) | [181](/filings/0000950170-25-030855.md) | [184](/filings/0000950170-24-056968.md) | [202](/filings/0000950170-24-094030.md) | [225](/filings/0000950170-24-125459.md) | [275](/filings/0001193125-26-098518.md) | [250](/filings/0000950170-25-069191.md) | [246](/filings/0001720592-25-000011.md) | [180](/filings/0001193125-25-274252.md) | [197](/filings/0001193125-26-342440.md) | [131](/filings/0001193125-26-204011.md) | [213](/filings/0001193125-26-342440.md) |
| Total assets | $m | [1,583](/filings/0000950170-23-062104.md) | [1,520](/filings/0000950170-25-030855.md) | [1,517](/filings/0000950170-24-056968.md) | [1,522](/filings/0000950170-24-094030.md) | [1,564](/filings/0000950170-24-125459.md) | [1,572](/filings/0001193125-26-098518.md) | [1,535](/filings/0000950170-25-069191.md) | [1,413](/filings/0001720592-25-000011.md) | [1,333](/filings/0001193125-25-274252.md) | [1,200](/filings/0001193125-26-342440.md) | [1,141](/filings/0001193125-26-204011.md) | [1,608](/filings/0001193125-26-342440.md) |
| Current liabilities | $m | [51.1](/filings/0000950170-23-062104.md) | [57.5](/filings/0000950170-25-030855.md) | [53.4](/filings/0000950170-24-056968.md) | [52.7](/filings/0000950170-24-094030.md) | [83.3](/filings/0000950170-24-125459.md) | [102](/filings/0001193125-26-098518.md) | [67.4](/filings/0000950170-25-069191.md) | [290](/filings/0001720592-25-000011.md) | [222](/filings/0001193125-25-274252.md) | [241](/filings/0001193125-26-342440.md) | [73.2](/filings/0001193125-26-204011.md) | [147](/filings/0001193125-26-342440.md) |
| Total liabilities | $m | [680](/filings/0000950170-23-062104.md) | [689](/filings/0000950170-25-030855.md) | [687](/filings/0000950170-24-056968.md) | [691](/filings/0000950170-24-094030.md) | [795](/filings/0000950170-24-125459.md) | [799](/filings/0001193125-26-098518.md) | [768](/filings/0000950170-25-069191.md) | [774](/filings/0001720592-25-000011.md) | [711](/filings/0001193125-25-274252.md) | [718](/filings/0001193125-26-342440.md) | [666](/filings/0001193125-26-204011.md) | [1,139](/filings/0001193125-26-342440.md) |
| Long-term debt | $m | [433](/filings/0000950170-23-062104.md) | [434](/filings/0000950170-25-030855.md) | [435](/filings/0000950170-24-056968.md) | [436](/filings/0000950170-24-094030.md) | [496](/filings/0000950170-24-125459.md) | [497](/filings/0001193125-26-098518.md) | [498](/filings/0000950170-25-069191.md) | [279](/filings/0001720592-25-000011.md) | [280](/filings/0001193125-25-274252.md) | [280](/filings/0001193125-26-342440.md) | [391](/filings/0001193125-26-204011.md) | [748](/filings/0001193125-26-342440.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [219](/filings/0001720592-25-000011.md) | [146](/filings/0001193125-25-274252.md) | [146](/filings/0001193125-26-342440.md) | [0.0](/filings/0001193125-26-204011.md) | [5.0](/filings/0001193125-26-342440.md) |
| Shareholders' equity | $m | [880](/filings/0000950170-23-062104.md) | [815](/filings/0000950170-25-030855.md) | [814](/filings/0000950170-24-056968.md) | [815](/filings/0000950170-24-094030.md) | [755](/filings/0000950170-24-125459.md) | [761](/filings/0001193125-26-098518.md) | [756](/filings/0000950170-25-069191.md) | [634](/filings/0001720592-25-000011.md) | [617](/filings/0001193125-25-274252.md) | [484](/filings/0001193125-26-342440.md) | [478](/filings/0001193125-26-204011.md) | [473](/filings/0001193125-26-342440.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [28.0 d](/filings/0000950170-24-125459.md) | [34.9 d](/filings/0001193125-26-098518.md) | [24.8](/filings/0000950170-25-069191.md) | [31.0 d](/filings/0001720592-25-000011.md) | [60.1 d](/filings/0001193125-25-274252.md) | [34.3 d](/filings/0001193125-26-098518.md) | [2.5](/filings/0001193125-26-204011.md) | [33.1 d](/filings/0001193125-26-342440.md) | [32.2 d](/filings/0001193125-25-274252.md) | [23.3 d](/filings/0001193125-26-098518.md) | [16.8](/filings/0001193125-26-204011.md) | [40.2 d](/filings/0001193125-26-342440.md) |
| Capital expenditure | $m | [0.9 d](/filings/0000950170-24-125459.md) | [(0.3) d](/filings/0001193125-26-098518.md) | [0.1](/filings/0000950170-25-069191.md) | [0.5 d](/filings/0001720592-25-000011.md) | [0.2 d](/filings/0001193125-25-274252.md) | [0.2 d](/filings/0001193125-26-098518.md) | [0.1](/filings/0001193125-26-204011.md) | [(0.1) d](/filings/0001193125-26-342440.md) | [0.1 d](/filings/0001193125-25-274252.md) | [0.1 d](/filings/0001193125-26-098518.md) | [0.1](/filings/0001193125-26-204011.md) | [2.2 d](/filings/0001193125-26-342440.md) |
| Share repurchases | $m | [0.1 d](/filings/0000950170-23-062104.md) | [0.4 d](/filings/0000950170-24-023102.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | billions of shares | [110](/filings/0000950170-23-062104.md) | [88.6](/filings/0000950170-24-056968.md) | [89.2](/filings/0000950170-24-094030.md) | [91.2](/filings/0000950170-24-125459.md) | [91.2](/filings/0000950170-25-069191.md) | [91.8](/filings/0001720592-25-000011.md) | [103](/filings/0001193125-25-274252.md) | [89.0](/filings/0001193125-26-204011.md) | [88.6](/filings/0001193125-26-342440.md) | [82.6](/filings/0001193125-25-274252.md) | [82.5](/filings/0001193125-26-204011.md) | [83.3](/filings/0001193125-26-342440.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.